{"company":{"id":720016,"name":"Cyclepharma","domain":"cyclepharma.com","url":"https://alion.io/company/cyclepharma"},"answer":"As of Nov 15, 2026, Alion lists 10 companies most like Cyclepharma: Dyne Therapeutics, AstraZeneca, Rezolute, Ascendis Pharma, Mirum Pharmaceuticals, Alkeus Pharmaceuticals, Vertex Pharmaceuticals, BridgeBio Pharma, Sanofi and Takeda Pharmaceutical.","highlights":["Cyclepharma itself has 14 open roles on Alion.","Of them, Takeda Pharmaceutical is hiring the most, with 1,137 open roles.","Open roles at BridgeBio Pharma rose the most: from 56 on Oct 12, 2026 to 72 now."],"as_of":"2026-11-15","cite":"Alion, \"Cyclepharma competitors and alternatives: 10 similar companies compared on hiring and funding\", as of Nov 15, 2026. https://alion.io/company/cyclepharma/competitors","indexable":true,"target":{"name":"Cyclepharma","url":"https://alion.io/company/cyclepharma","domain":"cyclepharma.com","open_roles":14,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":"venture","last_round_usd":null,"last_round_date":"2018-10-01","lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Cambridge","country":"GB"},"technologies":["Canva","ICH Guidelines","Veeva"],"hiring_countries":["US","GB"],"similarity":null},"competitors":[{"name":"Dyne Therapeutics","url":"https://alion.io/company/dyne-therapeutics","domain":"dyne-tx.com","open_roles":11,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"201-500","headquarters":{"city":"Waltham","country":"US"},"technologies":["GCP","Microsoft Excel","GMP"],"hiring_countries":["US"],"similarity":{"score":16.5,"shared_segments":["Prescription Drugs","Rare Disease Therapeutics"],"shared_technologies":["GCP","GMP","GLP","Good Clinical Practice","ICH Guidelines"],"same_hq_country":false}},{"name":"AstraZeneca","url":"https://alion.io/company/astra-zeneca","domain":"astrazeneca.com","open_roles":860,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"5000+","headquarters":{"city":"Cambridge","country":"GB"},"technologies":["Python","AI Agents","AWS"],"hiring_countries":["CN","US","ES"],"similarity":{"score":16.25,"shared_segments":["Prescription Drugs","Rare Disease Therapeutics"],"shared_technologies":["GCP","Canva","GMP","GLP","Good Clinical Practice"],"same_hq_country":true}},{"name":"Rezolute","url":"https://alion.io/company/rezolutebio","domain":"rezolutebio.com","open_roles":18,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"201-500","headquarters":{"city":"Redwood City","country":"US"},"technologies":["GCP","AWS","Azure"],"hiring_countries":["US"],"similarity":{"score":15.5,"shared_segments":["Prescription Drugs","Rare Disease Therapeutics"],"shared_technologies":["GCP","GMP","ICH Guidelines","Veeva","CAPA"],"same_hq_country":false}},{"name":"Ascendis Pharma","url":"https://alion.io/company/ascendispharma","domain":"ascendispharma.com","open_roles":33,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"1001-5000","headquarters":{"city":"Hellerup","country":"DK"},"technologies":["GCP","Databricks","dbt"],"hiring_countries":["DK","US","DE"],"similarity":{"score":15.25,"shared_segments":["Prescription Drugs","Rare Disease Therapeutics"],"shared_technologies":["GCP","Canva","GMP","Good Clinical Practice","Veeva"],"same_hq_country":false}},{"name":"Mirum Pharmaceuticals","url":"https://alion.io/company/mirum-pharmaceuticals-inc","domain":"mirumpharma.com","open_roles":38,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"201-500","headquarters":{"city":"Foster City","country":"US"},"technologies":["Power BI","SQL","Tableau"],"hiring_countries":["US","DE","CH"],"similarity":{"score":15,"shared_segments":["Prescription Drugs","Rare Disease Therapeutics"],"shared_technologies":["GCP","GMP","Veeva","CAPA"],"same_hq_country":false}},{"name":"Alkeus Pharmaceuticals","url":"https://alion.io/company/alkeuspharma","domain":"alkeuspharma.com","open_roles":2,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"11-50","headquarters":{"city":"Cambridge","country":"US"},"technologies":["GCP","CAPA","Good Clinical Practice"],"hiring_countries":["US"],"similarity":{"score":14.5,"shared_segments":["Prescription Drugs","Rare Disease Therapeutics"],"shared_technologies":["GCP","Good Clinical Practice","CAPA"],"same_hq_country":false}},{"name":"Vertex Pharmaceuticals","url":"https://alion.io/company/vrtx","domain":"vrtx.com","open_roles":233,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"5000+","headquarters":{"city":"Boston","country":"US"},"technologies":["GCP","AI Agents","Python"],"hiring_countries":["US","GB","DE"],"similarity":{"score":14.42,"shared_segments":["Prescription Drugs","Rare Disease Therapeutics"],"shared_technologies":["GCP","GMP","GLP","Good Clinical Practice","ICH Guidelines"],"same_hq_country":false}},{"name":"BridgeBio Pharma","url":"https://alion.io/company/bridgebiopharma","domain":"bridgebiopharma.com","open_roles":72,"open_roles_change":{"since":"2026-10-12","from":56,"to":72,"pct":29},"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"1001-5000","headquarters":{"city":"Palo Alto","country":"US"},"technologies":["Python","GCP","Claude"],"hiring_countries":["US","DE","CH"],"similarity":{"score":14.42,"shared_segments":["Prescription Drugs","Rare Disease Therapeutics"],"shared_technologies":["GCP","GMP","GLP","Good Clinical Practice","ICH Guidelines"],"same_hq_country":false}},{"name":"Sanofi","url":"https://alion.io/company/sanofi","domain":"sanofi.com","open_roles":714,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"5000+","headquarters":{"city":"Paris","country":"FR"},"technologies":["Python","Power BI","GMP"],"hiring_countries":["US","FR","CN"],"similarity":{"score":14.25,"shared_segments":["Prescription Drugs","Rare Disease Therapeutics"],"shared_technologies":["GCP","Canva","GMP","GLP","Good Clinical Practice"],"same_hq_country":false}},{"name":"Takeda Pharmaceutical","url":"https://alion.io/company/takeda","domain":"takeda.com","open_roles":1137,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"5000+","headquarters":{"city":"Tokyo","country":"JP"},"technologies":["GMP","SQL","Power BI"],"hiring_countries":["US","PL","IN"],"similarity":{"score":13.75,"shared_segments":["Prescription Drugs","Rare Disease Therapeutics"],"shared_technologies":["GCP","GMP","GLP","Good Clinical Practice","ICH Guidelines"],"same_hq_country":false}}],"method":"Ranked by Alion's similar-companies engine (the MCP tool similar_companies): shared industry segments and the overlap of the two segment sets, technologies named in both companies' job postings, the same headquarters country, a size band near it. Open roles are the visible postings on Alion today; their change is shown only for boards that state posting dates.","html_url":"https://alion.io/company/cyclepharma/competitors","json_url":"https://alion.io/company/cyclepharma/competitors.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","built_at":"2026-11-15T03:04:16Z","generated_at":"2026-11-20T00:19:43Z"}}